Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia

Clinical trial NCT01823315 · UNKNOWN

Trial details

NCT number: NCT01823315
Sponsor: Ding Ma
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Gestational Trophoblastic Disease Gestational Trophoblastic Neoplasia Gestational Trophoblastic Tumor Gestational Trophoblastic Neoplasms

Start date: 2012-12-01
Primary completion: 2015-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.